• Profile
Close

Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion

The American Journal of Surgery Aug 10, 2018

Qi YP, et al. - Researchers compared outcomes of patients with hepatocellular carcinoma (HCC) involving microvascular invasion (MVI) receiving adjuvant transarterial chemoembolization (A-TACE) after hepatic resection (HR) vs HR alone. This study included 200 consecutive patients with MVI-HCC who either underwent HR alone or HR with A-TACE. Using the Kaplan-Meier method, they compared disease-free survival (DFS) and overall survival (OS). The two groups were similar regarding DFS at 1, 2, and 3 years, but the A-TACE group had significantly higher OS in general, and significantly higher OS and DFS for those with tumor diameter > 5 cm or multinodular tumors.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay